Rovin, B. H., Ronco, P. M., Wetzels, J. F., Adler, S. G., Ayoub, I., Zaoui, P., . . . Sprangers, B. Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy. Elsevier.
Chicago Style (17th ed.) CitationRovin, Brad H., et al. Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy. Elsevier.
MLA (9th ed.) CitationRovin, Brad H., et al. Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy. Elsevier.
Warning: These citations may not always be 100% accurate.